PressNovember 12, 2020 NeonMind Obtains Health Canada Approval to Advance Psilocybin Research – Better Plant Sciences
PressNovember 12, 2020 European synthetic biology company Octarine raises $1.8M USD in funding and enters pre-clinical studies with novel-improved- cannabinoid and psychedelic derivatives
PressNovember 10, 2020 Red Light Holland to Acquire Wholesale Distribution Company in the Netherlands Providing Access to over 1,000 Retail Outlets in Multiple EU Countries
PressNovember 10, 2020 Mind Cure Announces Hiring of Award-Winning Experimental Scientist Dr. Ryan Hartwell as Chief Science Officer
PressNovember 9, 2020 COMPASS Pathways joins the Psychiatry Consortium in a collaboration to accelerate drug discovery in mental health care
PressNovember 5, 2020 Nova Mentis Life Science Acquisition Target, Pilz Bioscience Corp, Signs Psilocybin Manufacturing Agreement
PressNovember 2, 2020 MindMed Announces the Completion of Phase 1 Study Measuring Dosing Effects of LSD
PressOctober 30, 2020 MindMed Closes Upsized Financing of CAD $28.75m With Strong Institutional Demand for Psychedelic Medicines
PressOctober 29, 2020 Better Plant Receives Health Canada Approval for Plant-Based Antiseptic Skin Ointment
PressOctober 27, 2020 ATAI Life Sciences Announces Neuronasal Completes Pilot Study, Receives IND Clearance to Continue into Phase I Trials of mTBI Therapeutic
PressOctober 26, 2020 Field Trip Health Ltd. : Continues Expansion With Psychedelic-Enhanced Therapy Center in Chicago
PressOctober 22, 2020 Numinus First Canadian Public Company to Complete Legal Harvest of Psilocybe Mushrooms
PressOctober 21, 2020 Pharmather Files for FDA Orphan Drug Designation for Ketamine in Parkinson’s Disease
PressOctober 20, 2020 Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds
PressOctober 19, 2020 Cybin and Clarmin Announce Closing of CDN$45 Million Oversubscribed Private Placement and Provide Update on RTO
PressOctober 19, 2020 MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing
PressOctober 16, 2020 Universal Ibogaine Retains Westmount Park Investments for Corporate Financial Advisory Services
PressOctober 15, 2020 Pharmather Announces Exclusive License Agreement with the University of Arizona for the Commercialization of Ketamine in the Treatment of Parkinson’s Disease
